Article
San Francisco-April 13-The Light-Adjustable Lens (LAL) has entered humanclinical trials with promising results. Four humans-one blind and threewith sight-have received the lens, noted Robert K. Maloney, MD, chief medicalofficer, Calhoun Vision Inc, Pasadena, CA, who spoke at dinner gatheringin San Francisco.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.